Kulkarni Samarth
- SEC CIK
- 0001682019
In the past year, 7 open-market sale filings worth $10.8M and no purchases.
Current role at each company
- BDTX Black Diamond Therapeutics, Inc.Directoras of Jun 29, 2026
- CNTA Centessa Pharmaceuticals plcDirectoras of Jun 24, 2026
- ORKA Oruka Therapeutics, Inc.Directoras of Jun 3, 2026
- CRSP CRISPR Therapeutics AGChief Executive Officeras of Mar 24, 2026
- RPTX Repare Therapeutics Inc.Directoras of Jun 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $10.8M
- 7 filings
- Net
- −$10.8M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kulkarni Samarth as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRSP CRISPR Therapeutics AG
Chief Executive Officer36 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2026 (view filing) | Mar 23 | 1 day | Kulkarni SamarthChief Executive Officer | SSale | −10.0K | $46.78 | −$468.7K | −3.8%255.5K after | |
| Mar 17, 2026 (view filing) | Mar 16 | 1 day | Kulkarni SamarthChief Executive Officer | SSale | −10.3K | $48.26 | −$499.4K | −4.0%245.8K after | |
| Mar 12, 2026 (view filing) | Mar 11 | 1 day | Kulkarni SamarthChief Executive Officer | SSale | −9.80K | $52.80 | −$517.3K | −4.0%235.6K after | |
| Feb 20, 2026 (view filing) | Feb 19 | 1 day | Kulkarni SamarthChief Executive Officer | SSale | −6.97K | $52.58 | −$366.3K | −3.0%226.1K after | |
| Jan 22, 2026 (view filing) | Jan 20-22 | 2 days | Kulkarni SamarthChief Executive Officer | SSale | −90.0K | $57.40 | −$5.17M | −40.1%134.2K after | 3 lots10b5-1 |
| Oct 20, 2025 (view filing) | Oct 17 | 3 days | Kulkarni SamarthChief Executive Officer | SSale | −50.9K | $67.91 | −$3.46M | −16.7%254.2K after | |
| Oct 15, 2025 (view filing) | Oct 14 | 1 day | Kulkarni SamarthChief Executive Officer | SSale | −4.24K | $66.60 | −$282.5K | −2.0%205.1K after | |
| Aug 19, 2025 (view filing) | Aug 18 | 1 day | Kulkarni SamarthChief Executive Officer | SSale | −13.1K | $58.15 | −$760.7K | −5.9%207.0K after | |
| Mar 24, 2025 (view filing) | Mar 21 | 3 days | Kulkarni SamarthChief Executive Officer | SSale | −10.0K | $41.23 | −$413.6K | −4.9%195.1K after | |
| Mar 12, 2025 (view filing) | Mar 11-12 | 1 day | Kulkarni SamarthChief Executive Officer | SSale | −14.4K | $42.70 | −$616.3K | −7.2%185.4K after | 2 lots |